(PharmaNewsWire.Com, January 07, 2017 ) Gonorrhea Diagnostics Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Gonorrhea Diagnostics globally.
The Gonorrhea Diagnostics Market report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Gonorrhea Diagnostics Market:
Other Prominent Vendors of Gonorrhea Diagnostics Market Are:
Agilent Technologies Alere Becton Dickinson and Company Bio-Rad Cepheid
“A trend which is already contributing to market growth is the growing use of molecular diagnostics. Molecular diagnostics are used to study the chemical structure of DNA to determine the presence of an abnormal gene sequences, which could be the potential cause for the disease caused by an organism or pathogen. Therefore, physicians can isolate the specific gene polymorphisms causing the disease directly, or indirectly target DNA through amplification based on the amount of target DNA present. Molecular diagnostics represent the first step toward understanding a disease at the molecular level and is the fastest-growing clinical diagnostics technology.”
According to the Gonorrhea Diagnostics Market report, a key growth driver is the rising number of gonorrhea cases. The incidence of gonorrhea has been on the rise worldwide. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. In 2014, as per the estimates by CDC, there were around 350,062 reported cases of gonorrhea (a rate of 110.7 per 100,000) in the US. The highest incidence of gonorrhea was observed in heterosexually infected men, especially those aged 25-34 years. During the last 10 years, women constituted only around 20%-30% of all the reported cases of gonorrhea.
Report also presents Geographical Segmentation analysis of Gonorrhea Diagnostics Market of Americas, APAC, EMEA region.
Further, the Gonorrhea Diagnostics Market report states that one challenge that could restrict market growth is the lack of technical expertise. Gonorrhea diagnosis is highly complex and technical. An expert such as a specialized medical practitioner is required that can provide accurate and specific results to the patient.
Key questions answered in Gonorrhea Diagnostics market report:
What will the Gonorrhea Diagnostics market size be in 2020 and what will the growth rate be? What are the key market trends? What is driving Gonorrhea Diagnostics market? What are the challenges to Gonorrhea Diagnostics market growth? Who are the key vendors in Gonorrhea Diagnostics market space? What are the market opportunities and threats faced by the key vendors? What are the strengths and weaknesses of the key vendors?
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
